40 results on '"Samuel, Michelle"'
Search Results
2. Can We Define the Role of Cardiac Stress Testing After Percutaneous Coronary Intervention With the Use of Observational Data?
3. PO-05-175 THE TEMPORAL RELATIONSHIP BETWEEN VENTRICULAR ARRHYTHMIAS AND MORTALITY: INSIGHTS FROM THE RESYNCHRONIZATION IN AMBULATORY HEART FAILURE TRIAL (RAFT)
4. CI-452767-1 THE ASSOCIATION BETWEEN QRS NARROWING WITH CARDIAC RESYNCHRONIZATION THERAPY, MORTALITY AND HEART FAILURE: A POST-HOC ANALYSIS OF THE RESYNCHRONIZATION IN AMBULATORY HEART FAILURE TRIAL (RAFT)
5. Inflammation contributes to cardiovascular risk in patients receiving statin therapy
6. Ventricular Tachycardia and ICD Therapy Burden With Catheter Ablation Versus Escalated Antiarrhythmic Drug Therapy
7. Time in Therapeutic Range With Vitamin K Antagonists in Congenital Heart Disease: A Multicentre Study
8. PO-714-03 CLINICAL CHARACTERISTICS, MANAGEMENT, AND OUTCOMES IN A REAL-WORLD COHORT OF ADULT PATIENTS WITH SCAR-RELATED VENTRICULAR TACHYCARDIA
9. CI-545-01 RISK PREDICTION TOOL FOR CARDIAC PERFORATION DURING TRANSVENOUS LEAD EXTRACTION: A CANADIAN LEAD EXTRACTION RISK (CLEAR) STUDY SCORE
10. PO-648-05 PREDICTORS FOR TEMPORARY PACEMAKER USE IN PATIENTS WITH NEW LEFT BUNDLE BRANCH BLOCK AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION
11. EN-580-01 RISK PREDICTION TOOL FOR CARDIAC PERFORATION DURING TRANSVENOUS LEAD EXTRACTION: A CANADIAN LEAD EXTRACTION RISK (CLEAR) STUDY SCORE
12. Ventricular Tachycardia Burden and Mortality: Association or Causality?
13. Emulating a Randomised Controlled Trial With Observational Data: An Introduction to the Target Trial Framework
14. Effect of Perindopril on Atrial Fibrillation Recurrence and Burden: Results of the Canadian Trial of Atrial Fibrillation (CTAF)-2
15. Atrial arrhythmias and patient-reported outcomes in adults with congenital heart disease: An international study
16. Colchicine for Secondary Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials
17. SEX DIFFERENCES IN SYMPTOM REPORTING AMONGST ATRIAL FIBRILLATION ABLATION PATIENTS: A SUB-STUDY OF THE ADENOSINE FOLLOWING PULMONARY VEIN ISOLATION TO TARGET DORMANT CONDUCTION ELIMINATION (ADVICE) TRIAL
18. Anticoagulant Use and the Risk of Thromboembolism and Bleeding in Postoperative Atrial Fibrillation After Noncardiac Surgery
19. Distorting Effect of Immortal Time Bias on the Association Between Catheter Ablation for Atrial Fibrillation and Incident Stroke: Caveat Emptor
20. Pulmonary Vein Stenosis After Atrial Fibrillation Ablation: Insights From the ADVICE Trial
21. Will Colchicine Soon Be Part of Primary and Secondary Cardiovascular Prevention?
22. Population-Level Sex Differences and Predictors for Treatment With Catheter Ablation in Patients With Atrial Fibrillation and Heart Failure
23. Challenges in Assessing the Incidence of Atrial Fibrillation Hospitalizations
24. 116 Radiotherapy and Cardiovascular Implantable Electronic Devices - An Evidence-Based Guideline at Mcgill University
25. Incidence and Predictors of Intracardiac Thrombus on Pre-electrophysiological Procedure Transesophageal Echocardiography
26. Peripartum cardiomyopathy with co-incident preeclampsia: A cohort study of clinical risk factors and outcomes among commercially insured women
27. VALUE OF AORTIC PLAQUE IN PREDICTING LEFT ATRIAL APPENDAGE THROMBUS IN LOW RISK PATIENTS UNDERGOING ELECTROPHYSIOLOGICAL PROCEDURES
28. ANTICOAGULANT USE AND THE RISK OF THROMBOEMBOLISM AND BLEEDING IN PATIENTS WITH NEW ATRIAL FIBRILLATION FOLLOWING NON-CARDIAC SURGERY
29. Defining the pattern of initiation of monomorphic ventricular tachycardia using the beat-to-beat intervals recorded on implantable cardioverter defibrillators from the RAFT study: A computer-based algorithm
30. Assessment and Management of the Left Atrial Appendage Thrombus in Patients With Nonvalvular Atrial Fibrillation
31. Population-Based Evaluation of Major Adverse Events After Catheter Ablation for Atrial Fibrillation
32. Differences Between Conditional and Marginal Propensity Score Estimates
33. Long-term Follow-up of Coronary Artery Bypass Patients With Preoperative and New Postoperative Native Coronary Artery Chronic Total Occlusion
34. CATHETER ABLATION FOR THE TREATMENT OF ATRIAL FIBRILLATION REDUCES HEALTH CARE RESOURCE UTILIZATION
35. Health Care Goals, Communication, and Knowledge Among Older ICD Recipients
36. Prevalence and Outcomes of Patients Receiving Implantable Cardioverter-Defibrillators for Primary Prevention Not Based on Guidelines
37. B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias
38. Native Coronary Artery Patency After Coronary Artery Bypass Surgery
39. Statin therapy prevents expansive remodeling in venous bypass grafts
40. Current Perspectives on Coronary Chronic Total Occlusions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.